NASDAQ: XAGELongevity Health Holdings Revenue
Longevity Health Holdings revenue was $1.05M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $503.6k, down 1.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XAGE annual revenue was $50.3k, with Infinity% growth year-over-year.
XAGE past revenue growth
How has XAGE's revenue growth performed historically?
Company
8,438.66%
Industry
2.6%
Market
17.69%
XAGE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XAGE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
XAGE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
XAGE revenue history
Current Revenue
$1.1M
Current Earnings
-$7.2M
Current Profit Margin
-683%
Be the first to know when XAGE announces revenue.
XAGE Revenue History By Year
| XAGE Yearly Revenue | XAGE Revenue | XAGE Change | XAGE Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $50.32k | N/A | N/A |
| 2023-12-31 | $0.00 | N/A | N/A |
| 2022-12-31 | $0.00 | N/A | N/A |
| 2021-12-31 | $0.00 | N/A | N/A |
Longevity Health Holdings Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.